Indian-run Kusum pharma plant in Ukraine badly damaged in Russian drone strike, 1 killed

Indian-run Kusum pharma plant in Ukraine badly damaged in Russian drone strike, 1 killed

A pharmaceutical manufacturing facility operated by India-linked Kusum Group in Ukraine’s Sumy region was largely destroyed in a Russian drone attack on October 4, killing one person and injuring several others, according to Ukrainian officials and media reports.

The main structure of the facility sustained extensive damage in the attack. Videos from the site showed a large plume of smoke rising from the area after the drones struck. Officials cautioned that the number of casualties could change as emergency teams continued assessing the damage.

The facility is part of Kusum Group, a pharmaceutical company with Indian roots that has operated in Ukraine for decades. The group began its Ukraine operations in 1994 as a distributor of Indian medicines before moving into its own branded products and pharmaceutical manufacturing. It established its Sumy manufacturing facility in 2009.

Kusum Group is headed by Indian national Rajeev Gupta and describes itself as a Ukrainian company with Indian roots. The company produces more than 50 pharmaceutical products, mostly generics, and has markets in countries including Ukraine, Uzbekistan, Kazakhstan and the Philippines.

The Sumy facility had continued operating during the Russia-Ukraine war. Reports have estimated the damage from the latest attack at at least ₹400 crore, although the full financial impact is still being assessed.

Ukrainian President Volodymyr Zelensky condemned the attacks and expressed condolences to the family of the person killed. He said Russian drones also struck the Pivnichnyi Bridge in Kyiv and a communications facility in Dnipro, where six people were injured. Zelensky said Russia launched 135 attack drones against Ukraine overnight, including more than 50 jet-powered drones.

The attack comes amid an intensified Russian aerial campaign against Ukraine, with drones being used alongside missiles and other weapons. The damage to the Indian-linked pharmaceutical facility highlights the growing risks faced by businesses and industrial infrastructure operating in Ukraine during the ongoing war.